logo-loader

Toumaz CEO: SensiumVitals trials pave way towards full commercialisation

Published: 02:42 27 Jul 2015 EDT

Anthony Sethill, the chief executive of Toumaz (LON:TMZ) reckons the wireless semiconductor technologies company is 12 months away from seeing its SensiumVitals gain significant commercial traction.

SensiumVitals is a disposable ‘plaster’ about 15cm across that is stuck to the chest of patients when they enter hospital.  It contains a radio, a processor, and sensors for respiration, temperature and heart rate.

Figures are sent to hospital computers which can present them to nursing staff graphically, or raise alarms if figures suggest deterioration.

The product is being trialled at many hospitals around Europe and the Middle East, while St James's, one of the UK's most highly regarded hospitals, is also testing SensiumVitals.

EnWave expands partnership with MicroDried, signing new royalty-bearing...

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to announce a significant expansion of the company’s longstanding relationship with MicroDried, EnWave’s most established and high-capacity royalty partner. The latest agreement includes a new royalty-bearing commercial...

5 hours, 3 minutes ago
OSZAR »